Advancing diagnostics and therapy in transthyretin amyloid cardiomyopathy

被引：0
|
作者：
Holcman, Katarzyna [1 ,2 ]
Tkaczyszyn, Michal [3 ,4 ]
机构：
[1] Jagiellonian Univ, John Paul Hosp II, Dept Cardiac & Vasc Dis, Med Coll, Krakow, Poland
[2] St John Paul II Hosp, Dept Nucl Med, Krakow, Poland
[3] Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland
[4] Univ Hosp, Inst Heart Dis, Wroclaw, Poland
来源：
ESC HEART FAILURE | 2024年
关键词：
D O I：
10.1002/ehf2.15166
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Therapy of Transthyretin Cardiomyopathy
    Gertz, Morie A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) : 296 - 298
  • [32] Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
    Morfino, Paolo
    Aimo, Alberto
    Vergaro, Giuseppe
    Sanguinetti, Chiara
    Castiglione, Vincenzo
    Franzini, Maria
    Perrone, Marco Alfonso
    Emdin, Michele
    PHARMACEUTICS, 2023, 15 (04)
  • [33] Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
    Nakano, Tomoya
    Onoue, Kenji
    Terada, Chiyoko
    Terasaki, Satoshi
    Ishihara, Satomi
    Hashimoto, Yukihiro
    Nakada, Yasuki
    Nakagawa, Hitoshi
    Ueda, Tomoya
    Seno, Ayako
    Nishida, Taku
    Watanabe, Makoto
    Hoshii, Yoshinobu
    Hatakeyama, Kinta
    Sakaguchi, Yasuhiro
    Ohbayashi, Chiho
    Saito, Yoshihiko
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [34] POTENTIAL REVERSAL OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY WITH TTR SPECIFIC ANTISENSE OLIGONUCLEOTIDE THERAPY
    Dasgupta, Noel Rakhi
    Benson, Merrill D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 660 - 660
  • [35] Transthyretin Amyloid Cardiomyopathy Mimicking Hypertrophic Cardiomyopathy in an Older Patient
    Alves Guimaraes, Jose Pedro
    Trigo, Joana
    Goncalves, Fernando
    Ilidio Moreira, J.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (04) : 850 - 853
  • [36] Exercise And The Development Of Transthyretin Amyloid Cardiomyopathy - Is There An Association?
    Aiken, Achilles V.
    Tso, Jason V.
    Patel, Nikhil J.
    Mersola, Savannah
    Vescio, Robert
    Patel, Jignesh
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S27 - S27
  • [37] Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (05): : 505 - 505
  • [38] Tafamidis A Novel Treatment for Transthyretin Amyloid Cardiomyopathy
    Nawarskas, James J.
    Shephard, Emily A.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 156 - 160
  • [39] Screening for transthyretin amyloid cardiomyopathy in everyday practice
    Pablo Garcia-Pavia, P.
    Bokhari, S.
    Damy, T.
    Elliott, P.
    Fine, N.
    Gospodinova, M.
    Obici, L.
    Rapezzi, C.
    Witteles, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 127 - 127
  • [40] Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
    Fontana, Marianna
    Porcari, Aldostefano
    Hawkins, Philip N.
    GLOBAL HEART, 2023, 18 (01)
12345